Science in Sport plc (SIS.L)
- Previous Close
33.00 - Open
0.00 - Bid 32.40 x --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 34.00 - Volume
77,444 - Avg. Volume
315,283 - Market Cap (intraday)
75.975M - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.02 - Earnings Date Apr 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community in the United Kingdom, rest of Europe, the United States, and internationally. It operates through Science in Sport and PhD Nutrition segments. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; vitamins and supplements; whey powder and plant-based protein powders; high protein and low sugar foods, bars, and snacks; high protein and low sugar plant-based complete meal solution; and Reset, a night time formula. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains, and specialist sports retailers; grocers; and international retailers and distributors, as well as phd.com and scienceinsport.com digital platforms, and third-party online sites. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.
www.scienceinsport.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SIS.L
View MorePerformance Overview: SIS.L
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SIS.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SIS.L
View MoreValuation Measures
Market Cap
75.98M
Enterprise Value
90.67M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.28
Price/Book (mrq)
2.32
Enterprise Value/Revenue
1.75
Enterprise Value/EBITDA
41.80
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.14%
Return on Assets (ttm)
-3.29%
Return on Equity (ttm)
-15.33%
Revenue (ttm)
51.88M
Net Income Avi to Common (ttm)
-4.74M
Diluted EPS (ttm)
-0.02
Balance Sheet and Cash Flow
Total Cash (mrq)
1.97M
Total Debt/Equity (mrq)
50.83%
Levered Free Cash Flow (ttm)
574.12k